Celcuity

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.

CEO

Brian F. Sullivan

CEOBrian F. Sullivan

Employees

Employees87

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

2012

Founded2012

Employees

Employees87

CELC Key Statistics

Market cap

437.74M

Market cap437.74M

Price-Earnings ratio

-3.83

Price-Earnings ratio-3.83

Dividend yield

—

Dividend yield—

Average volume

144.22K

Average volume144.22K

High today

$12.15

High today$12.15

Low today

$11.54

Low today$11.54

Open price

$11.93

Open price$11.93

Volume

174.90K

Volume174.90K

52 Week high

$19.77

52 Week high$19.77

52 Week low

$7.58

52 Week low$7.58

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.

Celcuity

Why Robinhood?

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Show more

CELC Key Statistics

Analyst ratings

100%

People also own

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.